GlassScriptPhysician profile
Jacob C West
NPI 1801109525
$619.23
in general payments reported to CMS, 2019-2025
9 companies · $79.42 in 2025
The $79.42 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.02 · 2021: $17.60 · 2022: $156 · 2023: $180 · 2024: $161 · 2025: $79.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $186.05 | 2022-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $177.92 | 2022-2024 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $74.32 | 2019-2023 | Myday Contact Lens |
| Sight Sciences, INC. | $61.01 | 2024-2025 | Tearcare System |
| Oyster Point Pharma, INC. | $48.00 | 2022-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $27.24 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $18.13 | 2025 | Xdemvy |
| Alcon Vision LLC | $13.41 | 2024 | Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.